Monthly News Roundup - July 2022

GSK’s Benlysta Is First Approved Treatment for Pediatric Lupus Nephritis Benlysta (belimumab) is now approved for children 5 to 17 years of age who have lupus nephritis and are receiving standard therapy. Benlysta is not recommended in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news